"To my knowledge, it can only be the Mass Gen Dana Farber Abi combo..." It is, he even mentioned Dana Farber by name. Not much new, but that in itself is good news. Expect pivotal trials in HCC and RCC to be formally announced soon.
On page 11 of the slide under IST randomized phase 2 studies, I see CRPC combo with hormonal agents in prechemo setting. I thought I heard an air of early enthusiasm on phase one early results.---has me wondering if I heard that right? Sounds like you heard the same enthusiasm for early combo with abiraterone from the call as well. I wonder when we could get a peek at the early results in an upcoming conference?